Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Transocean Ltd — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while Transocean Ltd trades at $5.58 (market cap $6.31B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 4.9× Transocean Ltd's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals.
| GEHC | RIG | |
|---|---|---|
Market Cap | $31.07B | $6.31B |
Volume | 3,443,020 | 37,551,905 |
Sector | Health | Energy |
52-Week High | $88.16 | $7.58 |
52-Week Low | $59.48 | $3.23 |
Enterprise Value | $39.53B | $10.92B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 18 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Transocean (RIG) trades at $5.65, up 0.89% today, with a bullish technical signal from moving averages. The company shows mixed fundamentals with strong revenue growth to $4.1B in 2026 but persistent net losses. Recent contract wins including an $80M Equatorial Guinea deal and DOJ approval for the $5.8B Valaris acquisition provide positive catalysts. Cash flow improvement is notable with operating cash flow reaching $995M in 2026.
RIG presents a speculative opportunity driven by offshore cycle strength and deleveraging potential, but high debt levels and negative profitability pose significant risks. Analyst consensus is divided with 39% buy ratings, reflecting optimism about contract backlog versus concerns about execution and financial leverage. The stock's upside depends on successful debt reduction and sustained offshore drilling demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
